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A B S T R A C T
Purpose: We present de case of a 27-year-old woman admitted to ICU after scheduled splenectomy to
study her short course of fever, leukopenia and splenic space-occupying lesions and splenomegaly. She
has been previously treated with Infliximab due to indeterminate colitis and completed correct
tuberculosis prophylaxis.
Materials and methods: We reviewed our case in our regional Electronic Health DataBase IANUS and
compared it with other case reports in literature, found in PubMed, with keywords tuberculosis,
inflammatory disease and hemophagocytic lymphohistiocytosis.
Results: After splenectomy, she needed intensive care due to acute respiratory failure, alveolar-interstitial
pulmonary infiltrates, right pleural effusion and fever. Bone marrow aspirate resulted in hemophagocytic
lymphohistiocytosis. Only multidisciplinary management in ICU and combined treatment with
chemotherapy for hemophagocytic syndrome and tuberculostatics achieved her curation.
Conclusion: Tuberculosis must always be considered in the differential diagnosis of hemophagocytic
lymphohistiocytosis and acute respiratory failure despite correct prior prophylaxis.
© 2019 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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journal homepage: www.elsevier .com/ locate / idcrIncidence of disseminated tuberculosis in Spain has risen, in last
two decades [1], but remains relatively low. This incidence
increases in immunocompromised patients, so tuberculosis
prophylaxis with Isoniazid is completed before starting anti-TNK
treatments in autoimmune chronic diseases [2,3]. Differential
diagnosis of any serious clinical picture with multiorgan involve-
ment should include tuberculosis [4,5], even if previously
chemoprophylaxis has been properly completed.
A 27-year-old woman with a history of anxiety-depressive
syndrome, polycystic ovarian syndrome and inflammatory bowel
disease (indeterminate to colitis). She had been treated over three
years with immunosuppressive therapy (systemic corticosteroids,
azathioprine and infliximab). She had received, with non-clinical* Corresponding author at: Instituto de Investigación Sanitaria Galicia Sur (IIGS).
E-mail addresses: modefi@arrakis.es, modesto.martinez.pillado@sergas.es
(M. Martínez-Pillado).
https://doi.org/10.1016/j.idcr.2019.e00518
2214-2509/© 2019 The Authors. Published by Elsevier Ltd. This is an open access article unevidence of previous PPD +, proper TB prophylaxis (isoniazid, INH)
for nine months before starting the biological treatment.
Case report
She was admitted to hospital presenting 3-days high fever (up
to 39 C), leukopenia, proctitis, splenic space-occupying lesions
and splenomegaly, suspecting lymphoma or splenic abscesses.
Bone marrow aspirate results in a hemophagocytic lymphohis-
tiocytosis. Microbiological (BAAR) serological (VIH,etc) results
blood were all negative.
Because of a rapid clinical deterioration, splenectomy in
hospital day five, and liver biopsy were performed in day six.
Two days after surgery she developed acute respiratory failure in
second day after surgery, alveolar-interstitial pulmonary infil-
trates, right pleural effusion and fever. Echo-guided thoracentesis
of right pleural effusion, lumbar puncture, bronchoscopy with
bronchoalveolar lavage were performed and antibiotic empiric
therapy with Meropenem, Linezolid, empiric therapy antifungal,der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
2 M. Martínez-Pillado et al. / IDCases 16 (2019) e00518Pneumocystis jirovecii prophylaxis with Trimethoprim-Sulfa-
methoxazole and tuberculostatic quadruple therapy were started.
Criteria for hemophagocytic syndrome wermet: fever > 38,5 C,
splenomegaly, hypertriglyceridemia (326 mg/dl), ferritin > 500
and hemophagocytosis demonstrated in bone marrow aspirate.
Empirical treatment for histiocytes and lymphocytes proliferation
was started with Dexamethasone 10 mg / m2 daily and etoposide
150 mg / m2.
On the 4th day of admission in ICU, Total Parenteral Nutrition
was started and she remained sedated and intubated. On 7th day,
after receiving negative tests for tuberculosis in cerebrospinal fluid
(absence of acid-alcohol resistant bacilli), intrathecal Methotrexate
was started. On 10th day of admission, extubation was successful
and pathology results from spleen and liver revealed a necrotizing
granulomatous reaction with the presence of acid-fast bacilli.
After being assessed by Psychiatry because of a reactive anxiety
syndrome, anxiolytic benzodiazepines an antidepressant were
restarted, and she was moved to Internal Medicine ward.
Hepatization in lung right lower lobe was demonstrated by
thoracic ultrasound and diagnostic thoracentesis was performed in
which laboratory results were consistent with pleural tuberculosis.
The isolate was found to be pan-sensitive and she successfully
complete therapy for ten days and anti TNF-therapy continued.
Discussion heading the importance of this case, is given by
association between hemophagocytic syndrome and disseminatedtuberculosis in an immunosuppressed patient and the outcrop of
this infectious disease that must always be considered in the
differential diagnosis of fever despite correct prior prophylaxis.
Therefore, it is an opportunity to focus on the efficacy of anti-TB
chemoprophylaxis in latent TB infected patients who are to receive
anti-TNF. In each case, we must decide if anti-TNF and chemopro-
phylaxis must be appropriate, as this case report showed.
Multidisciplinary management in the ICU is always mandatory
to achieve curation.
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